Exercise Prescriptions for Patients With Cardiovascular Disease

July 4, 2022 updated by: Dominique Hansen, Hasselt University

Are Exercise Prescriptions for Patients With Cardiovascular Disease, Made by Physiotherapists, in Agreement With International Guidelines?

Physiotherapists are often confronted with patients with (elevated risk for) cardiovascular disease (CVD), even when this is not the primary indication for physiotherapy. Hence, physiotherapists should be able to provide evidence-based exercise advice to these patients, but this has not been assessed. The aim of this study was therefore to assess whether exercise prescriptions by physiotherapists to patients with CVD are in accordance with international recommendations.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In this prospective observational survey, forty-seven Belgian physiotherapists agreed to prescribe exercise intensity, frequency, session duration, program duration, and exercise type (endurance or strength training) for the same three patient cases. Exercise prescriptions were compared between clinicians and relations with clinician characteristics were studied. In addition, the agreement between physiotherapists' exercise prescriptions and those from international recommendations (based on a maximal score of 60/per case) was assessed.

Study Type

Observational

Enrollment (Actual)

47

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Belgium
    • Limburg
      • Diepenbeek, Limburg, Belgium, 3590
        • Hasselt University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Professionaly active Flemish physiotherapists.

Description

Inclusion Criteria: Currently professionally active Flemish physiotherapists

Exclusion Criteria: Not having access to a device that allows the use of the EXercise Prescription in Everyday practice & Rehabilitative Training (EXPERT) tool.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise intensity
Time Frame: February - April 2022
Assessment of the prescription of exercise intensity (expressed in heart rate in beats per minute)
February - April 2022
Exercise frequency
Time Frame: February - April 2022
Assessment of exercise frequency (expressed in number of exercise sessions per week)
February - April 2022
Session duration
Time Frame: February - April 2022
Assessment of session duration (expressed in number of minutes)
February - April 2022
Program duration
Time Frame: February - April 2022
Assessment of program duration (expressed in number of weeks)
February - April 2022
Exercise type
Time Frame: February - April 2022
Aerobic exercise or strength exercise
February - April 2022
Total exercise volume
Time Frame: February - April 2022
Multiplication of number of prescribed weeks, number of prescribed sessions/week, prescribed individual session duration and prescribed exercise intensity
February - April 2022

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Association between exercise prescriptions and clinician characteristics'
Time Frame: February - April 2022
Relations between exercise prescriptions (intensity, frequency, session/program duration, exercise type) and clinician characteristics (age, gender, education, experience,...) were studied.
February - April 2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hasselt University

Investigators

  • Principal Investigator: Dominique Hansen, Prof, Hasselt University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 16, 2022

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

April 30, 2022

Study Registration Dates

First Submitted

July 4, 2022

First Submitted That Met QC Criteria

July 4, 2022

First Posted (Actual)

July 8, 2022

Study Record Updates

Last Update Posted (Actual)

July 8, 2022

Last Update Submitted That Met QC Criteria

July 4, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AXXON

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on To prescribe exercise prescription for CVD patients

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe